BiotechTube
Home/CND Life Sciences/Kathryn Van Wie, Esq.
KV

Kathryn Van Wie, Esq.

General Counsel & SVP, Commercial Strategy & Market Development

CND Life Sciences

Therapeutic Areas

Parkinson's DiseaseSynucleinopathiesNeurodegenerative Diseases

CND Life Sciences Pipeline

DrugIndicationPhase
Syn-One Test CommercializationParkinson's Disease, Dementia with Lewy Bodies, Multiple System AtrophyCommercial
Biomarker Services for BiopharmaSynucleinopathies (Clinical Trial Support)Commercial/Service
Small-Fiber DxSmall Fiber NeuropathyCommercial